Note: This grant page has been archived and is very likely out of date.

Emergency Awards: Rapid Investigation of Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) and Coronavirus Disease 2019 (COVID-19) (R21 Clinical Trial Not Allowed)

US Dept. of Health & Human Services: National Institutes of Health (NIH)

Suggest an update

Deadline: The deadline for this grant has passed

Grant amount: Up to US $275,000

Fields of work: Respiratory Diseases & Systems

Applicant type: Organizations

Funding uses: Non-clinical Behavioral, Non-clinical Biomedical

Location of project: Anywhere in the world

Location of residency: Anywhere in the world

Overview:

NOTE: In accordance with NOT-AI-20-063, applications will no longer be accepted to this FOA after August 14, 2020. After this date, applicants are encouraged to consider applying to PA-20-195, NIH Exploratory/Developmental Research Grant Program (Parent R21 Clinical Trial Not Allowed).

The purpose of this Funding Opportunity Announcement (FOA) is to provide an expedited (rapid) funding mechanism for research on Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) and Coronavirus Disease 2019 (COVID-19).

We've imported the main document for this grant to give you an overview. You can learn more about this opportunity by visiting the funder's website.

This page was last reviewed August 10, 2020 and last updated July 17, 2020